Cosali cohort | PREDICTS cohort | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | nCTS | %CTS | OR crude | OR adjusted (variables showed) | N | CTS | %CTS | OR crude | OR adjusted (variables showed) | |
Age (years). | ||||||||||
<30 | 271 | 3 | 1.11 | 1.00 | 1.00 | 412 | 14 | 3.4 | 1.00 | 1.00 |
0–39 | 513 | 13 | 2.53 | 2.32 (0.66; 8.22) | 2.42 (0.68; 8.62) | 145 | 6 | 4.14 | 1.23 (0.46; 3.26) | 1.19 (0.44; 3.25) |
40–49 | 583 | 14 | 2.4 | 2.20 (0.63; 7.71) | 2.06 (0.58; 7.32) | 97 | 6 | 6.19 | 1.87 (0.70; 5.01) | 1.11 (0.36; 3.41) |
≥50 | 182 | 6 | 3.3 | 3.04 (0.75; 12.33) | 2.93 (0.71; 12.20) | 57 | 5 | 8.77 | 2.73 (0.95; 7.90) | 1.49 (0.42; 5.28) |
Sex | ||||||||||
Male | 893 | 11 | 1.23 | 1.00 | 1.00 | 458 | 18 | 3.93 | 1.00 | 1.00 |
Female | 658 | 25 | 3.8 | 3.17 (1.55; 6.48)* | 3.24 (1.56; 6.73)* | 253 | 13 | 5.14 | 1.32 (0.64; 2.75) | 1.74 (0.73; 4.11) |
Body mass index (kg/m2) | ||||||||||
<18.5 | 57 | 2 | 3.51 | 1.49 (0.34; 6.48) | 12 | 1 | 8.33 | 6.91 (0.66; 71.91) | ||
18.5–24.9 | 921 | 22 | 2.39 | 1.00 | 231 | 3 | 1.3 | 1.00 | ||
25–29.9 | 439 | 7 | 1.59 | 0.66 (0.28; 1.56) | 237 | 10 | 4.22 | 3.35 (0.91; 12.32) | ||
≥30 | 112 | 5 | 4.46 | 1.91 (0.71; 5.15) | 231 | 17 | 7.36 | 6.04 (1.74; 20.89)* | ||
Obesity (kg/m2) | ||||||||||
≤30 | 1439 | 31 | 2.15 | 1.00 | 1.00 | 480 | 14 | 2.92 | 1.00 | 1.00 |
>30 | 112 | 5 | 4.46 | 2.12 (0.81; 5.57) | 1.89 (0.70; 5.13) | 231 | 17 | 7.36 | 2.64 (1.28; 5.46)* | 1.89 (0.84; 4.25) |
Thyroid disorders | ||||||||||
No | 1485 | 35 | 2.36 | 1.00 | 696 | 30 | 4.31 | 1.00 | ||
Yes | 59 | 1 | 1.69 | 0.71 ( 0.10; 5.30) | 15 | 1 | 6.67 | 1.59 (0.20; 12.46) | ||
Diabetes mellitus | ||||||||||
No | 1526 | 35 | 2.29 | 1.00 | 695 | 29 | 4.17 | 1.00 | ||
Yes | 17 | 1 | 5.88 | 2.66 (0.34; 20.64) | 16 | 2 | 12.5 | 3.28 (0.71; 15.11) | ||
Rheumatism arthritis | ||||||||||
No | 1515 | 35 | 2.31 | 1.00 | 701 | 30 | 4.28 | 1.00 | ||
Yes | 28 | 1 | 3.57 | 1.57 (0.21; 11.85) | 10 | 1 | 10 | 2.49 (0.30; 20.26) | ||
Thyroid disorders or diabetes or arthritis | ||||||||||
No | 1458 | 33 | 2.26 | 1.00 | 1.00 | 672 | 27 | 4.02 | 1.00 | 1.00 |
Yes | 93 | 3 | 3.23 | 1.44 (0.43; 4.78) | 0.90 (0.25; 3.15) | 39 | 4 | 10.26 | 2.73 (0.91; 8.23) | 2.37 (0.70; 7.99) |
Computer work exposure† | ||||||||||
1 | 611 | 22 | 3.6 | 1.00 | 1.00 | 355 | 23 | 6.48 | 1.00 | 1.00 |
2 | 234 | 5 | 2.14 | 0.58 (0.22; 1.56) | 0.60 (0.22; 1.63) | 77 | 2 | 2.6 | 0.38 (0.09; 1.67) | 0.38 (0.09; 1.67) |
3 | 219 | 1 | 0.46 | 0.12 (0.02; 0.92)* | 0.13 (0.02; 1.01) | 52 | 1 | 1.92 | 0.28 (0.04; 2.14) | 0.20 (0.03; 1.62) |
4 | 482 | 8 | 1.66 | 0.45 (0.20; 1.02) | 0.39 (0.17; 0.89)* | 202 | 3 | 1.49 | 0.22 (0.06; 0.73)* | 0.16 (0.05; 0.59)* |
* p<0.05 (bold).
†For the Cosali cohort, report duration of computer screen exposure 1=Never or almost never (reference), 2=Less than 2 h/day, 3=2 to 4 h/day, 4=all or almost all of the working day; for the PrediCTS cohort, absolute number of the O*NET scale.
%CTS, proportion of CTS; n, CTS number of carpal tunnel syndrome; N, number of participants.